Samsung BioLogics' Revised Valuation Based on P/B Multiple
In another regulatory filing, Samsung BioLogics presented a revised valuation based on P/B multiple. Obviously, there are still many people who are...
354 Views
Pass on the Deal, Put on the Watchlist
This Insight finalizes our view of the listing of Samsung BioLogics (SB) using information presented at the company’s roadshow meeting and included...
360 Views
4 Main Issues at Samsung Electronics EGM on Oct 27
What can we really expect from Samsung Electronics' extraordinary general meeting scheduled for Thursday (Oct 27) this week?SEC's EGM...
257 Views
Reasons Why DRAM Price Might Be Better than NAND in 2017
Executive summary DRAM spot price much stronger than NAND's in 4Q16: After over 10% hike in DRAM/NAND spot/contract price in 3Q16, we see another...
466 Views
3 Main Debatable Points to Be Discussed in Samsung BioLogics NDR This Week
Samsung BioLogics is quite busy with NDR this week. BioLogics executives are doing their best to justify the proposed valuation for BioLogics IPO....
353 Views